Asterion will be developing the largest purpose-built renewable powered medicinal cannabis greenhouse facility in the developed world with an expected capacity in excess of 500,000 kg per annum.
The greenhouse will house 4.3 million square feet (~40 ha) of cultivation space with growing and environment systems designed for optimal consistent high-volume output. Purpose-built with the most advanced agronomy, horticultural science and technology.
The development will be in three stages consisting of Phase 1) 10 ha greenhouse, plus the manufacturing facility; Phase 2) an additional 10 ha greenhouse; plus Phase 3) 20 ha greenhouse.
Asterion will be a fully integrated medicinal cannabis pharmaceutical company with a range of products for provision to patients in Australia and overseas. We will supply cannabis flower, oil and gelatin capsules in a range of THC and CBD concentrations.
We will also supply concentrated cannabinoids to be incorporated as the active pharmaceutical ingredients (APIs) in a range of delivery systems, such as edibles/pastilles, sold by third party partners.
All intermediate and finished products will be manufactured within our on-site EU-GMP facility.